4Chhieng DC,Yee H,Schaefer D,et al.Calretinin staining pattern aids in the differentiation of mesothelioma from adenocarcinoma in serous effusions.Cancer,2000,90 (3):194-200.
5Politi E,Kandaraki C,Apostolopoulou C,et al.Immunocytochemical panel for distinguishing between carcinoma and reactive mesothelial cells in body cavity fluids.Diagn Cytopathol,2005,32(3):151-155.
6Oode K,Furuya T,Harada K,et al.The development of a cell array and its combination with laser-scanning cytometry allows a highthroughput analysis of nuclear DNA content.Am J Pathol,2000,157(3):723-728.
7Ziauddin J,Sabatini DM.Microarrays of cells expressing defined cDNAs.Nature,2001,411 (6833):107-110.
8Belov L,de la Vega O,dos Remedios CG,et al.Immunophenotyping of leukemias using a cluster of differentiation antibody microarray.Cancer Res,2001,61 (11):4483-4489.
9Fuhrman C,Duche JC,Chouaid C,et al.Use of tumor markers for differential diagnosis of mesothelioma and secondary pleural malignancies.Clin Biochem,2000,33(5):405-410.
10Porcel JM,Vives M,Esquerda A,et al.Use of a panel of tumor markers (carcinoembryonic antigen,cancer antigen 125,carbohydrate antigen 15-3,and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions.Chest,2004,126(6):1757-1763.
